https://bw759inhibitor.com/fac....tors-behind-demise-i
We also determined whether utilising the rating to choose a small grouping of customers with additional severe disease would decrease sample sizes for clinical input trials. Leads to a pooled analysis of most 3 cohorts, the score enhanced prediction of dementia (area beneath the curve [AUC], 0.85; 95% confidence interval [CI], 0.81-0.89) compared to that from medical risk aspects alone (AUC, 0.76; 95% CI, 0.71-0.81). Predictive performance ended up being greater in customers with more severe SVD. Po
Beğen
Yorum Yap
Paylaş
